How should nausea be managed, including non‑pharmacologic measures and first‑line antiemetics?

Nausea Management

For acute nausea and vomiting in adults, start with ondansetron as first-line therapy due to its superior safety profile (no sedation or akathisia), reserving dopamine antagonists like prochlorperazine or metoclopramide as second-line options when sedation is acceptable or ondansetron fails.

Initial Assessment and Risk Stratification

Before initiating treatment, determine:

• Acute vs. chronic: Symptoms lasting <7 days are acute; ≥4 weeks are chronic 1
• Medication/toxin review: This is the most common reversible cause and must be evaluated immediately 2
• Alarm symptoms: Severe abdominal pain, neurologic deficits, severe dehydration, or signs of obstruction require urgent evaluation rather than empiric treatment 1

For mild acute symptoms without alarm features, proceed directly to treatment without extensive testing 2.

Non-Pharmacologic Measures

Implement these foundational interventions for all patients:

• Fluid and electrolyte replacement: Use normal saline (0.9% NaCl) for IV hydration when needed 3
• Dietary modifications: Small, frequent meals; avoid trigger foods 1
• Complementary therapies with evidence:
  • Acupuncture/acupressure reduces postoperative nausea 4
  • Aromatherapy and ginger (oral intake) show benefit 4
  • Music therapy decreases incidence and improves quality of life 4

First-Line Pharmacologic Management

For General Adult Populations (Non-Pregnancy, Non-Chemotherapy)

Ondansetron (5-HT3 antagonist) is the optimal first-line choice 5:

• Equally effective as promethazine for symptom relief
• No sedation or akathisia risk
• Safe across most patient populations
• Administer IV or orally depending on severity

Second-Line Options When First-Line Fails

If ondansetron is ineffective, escalate based on clinical context:

Prochlorperazine or Metoclopramide (dopamine antagonists) 5:

• More effective than ondansetron in some studies but carry akathisia risk
• Critical caveat: Akathisia can develop anytime within 48 hours post-administration
• Mitigation: Slow IV infusion rate reduces akathisia incidence
• Treatment: IV diphenhydramine if akathisia occurs
• Metoclopramide specifically: Use slow bolus over ≥3 minutes to minimize extrapyramidal effects 3

Promethazine (H1-antihistamine) 5:

• Consider when sedation is desirable
• Warning: Risk of vascular damage with IV administration
• More sedating than alternatives

Avoid as First-Line

Droperidol: Reserve only for refractory cases due to FDA black box warning for QT prolongation 5

Special Population Considerations

Pregnancy-Related Nausea (NVP/Hyperemesis Gravidarum)

First-line options with safety data 3:

• H1-antihistamines
• Phenothiazines
• Doxylamine/pyridoxine combination

Ondansetron for pregnancy: Safe and effective as second-line when first-line fails 3. The absolute risk increase for orofacial clefting in first trimester is very small and should be balanced against risks of poorly managed hyperemesis.

Additional pregnancy-specific measures 3:

• Thiamine supplementation (100 mg TID oral or IV Pabrinex) for all admitted patients with vomiting or severely reduced intake, especially before dextrose/parenteral nutrition
• Combination therapy: Use multiple drug classes if single agents fail
• Do not use ketonuria to assess severity—it's not a dehydration indicator 3

Chemotherapy-Induced Nausea

For breakthrough nausea despite prophylaxis 6:

• Add olanzapine if not already receiving it (evidence-based, moderate strength)
• If already on olanzapine, add different drug class: NK1 antagonist, benzodiazepine, dopamine antagonist, or cannabinoid

Chronic Nausea (≥4 Weeks)

Chronic nausea pathophysiology resembles neuropathic pain rather than acute emesis 7. Traditional antiemetics are historically less effective.

Neuromodulator agents show efficacy 7:

• Tricyclic antidepressants
• Gabapentin
• Olanzapine
• Mirtazapine
• Benzodiazepines
• Cannabinoids

When specific etiology is unidentified, start with serotonin or dopamine antagonist, but consider neuromodulators early if conventional therapy fails 1.

Key Clinical Pitfalls

1. Duration of therapy: Use antiemetics for the shortest time necessary to control symptoms 1
2. Akathisia monitoring: Patients on prochlorperazine/metoclopramide need 48-hour surveillance 5
3. Promethazine IV administration: High risk of tissue damage; consider alternative routes 5
4. Pregnancy ketonuria: Do not use to guide treatment decisions 3
5. Chronic symptoms: Don't persist with conventional antiemetics if ineffective—pivot to neuromodulators 7

Treatment Algorithm Summary

1. Assess acuity (acute vs. chronic) and review medications/toxins
2. Acute mild-moderate without alarm features: Start ondansetron
3. If ondansetron fails: Add prochlorperazine or metoclopramide (monitor for akathisia)
4. If sedation desired: Use promethazine
5. Chronic symptoms: Consider neuromodulators (TCAs, gabapentin, olanzapine) early
6. Pregnancy: H1-antihistamines or phenothiazines first; ondansetron second-line
7. Always implement: Fluid replacement, dietary modifications, and evidence-based complementary therapies